OracleBio will be attending the Next Gen Immuno-Oncology Congress, which takes place from the 13th to the 14th of March in London.
OracleBio provides a range of digital pathology image analysis services that support pre-clinical and clinical Immuno-Oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. To find out more about OracleBio’s Immuno-Oncology services, please click here.
The Next Gen Immuno-Oncology Congress brings together academics, researchers and scientists from research institutes, Biotech and Pharma companies, to discuss the growth of existing therapeutics and pave the way for emerging next generation therapeutics. To find out more about the congress, please click here.
If you would like to find out more about OracleBio’s services, or if you wish to arrange a time to speak with OracleBio’s European Business Manager, Clíona MacSweeney, during the congress, please contact us.
To keep up to date with all OracleBio news, please follow us on LinkedIn by clicking on the button below: